<?xml version="1.0" encoding="UTF-8"?>
<questel-patent-document lang="en" date-produced="20180805" produced-by="Questel" schema-version="3.23" file="US06180584B2.xml">
  <bibliographic-data lang="en">
    <publication-reference publ-desc="Granted patent as second publication">
      <document-id>
        <country>US</country>
        <doc-number>06180584</doc-number>
        <kind>B2</kind>
        <date>20010130</date>
      </document-id>
      <document-id data-format="questel">
        <doc-number>US6180584</doc-number>
      </document-id>
    </publication-reference>
    <original-publication-kind>B2</original-publication-kind>
    <application-reference family-id="22119663" extended-family-id="54060">
      <document-id>
        <country>US</country>
        <doc-number>09248861</doc-number>
        <kind>A</kind>
        <date>19990211</date>
      </document-id>
      <document-id data-format="questel">
        <doc-number>1999US-09248861</doc-number>
      </document-id>
      <document-id data-format="questel_Uid">
        <doc-number>55637</doc-number>
      </document-id>
    </application-reference>
    <language-of-filing>en</language-of-filing>
    <language-of-publication>en</language-of-publication>
    <priority-claims>
      <priority-claim kind="national" sequence="1">
        <country>US</country>
        <doc-number>24886199</doc-number>
        <kind>A</kind>
        <date>19990211</date>
        <priority-active-indicator>N</priority-active-indicator>
      </priority-claim>
      <priority-claim data-format="questel" sequence="1">
        <doc-number>1999US-09248861</doc-number>
      </priority-claim>
      <priority-claim kind="national" sequence="2">
        <country>US</country>
        <doc-number>7445698</doc-number>
        <kind>P</kind>
        <date>19980212</date>
        <priority-active-indicator>Y</priority-active-indicator>
      </priority-claim>
      <priority-claim data-format="questel" sequence="2">
        <doc-number>1998US-60074456</doc-number>
      </priority-claim>
    </priority-claims>
    <dates-of-public-availability>
      <publication-of-grant-date>
        <date>20010130</date>
      </publication-of-grant-date>
    </dates-of-public-availability>
    <classifications-ipcr>
      <classification-ipcr sequence="1">
        <text>A01N  25/10        20060101A I20051008RMEP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>25</main-group>
        <subgroup>10</subgroup>
        <classification-value>I</classification-value>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20051008</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="2">
        <text>A01N  25/24        20060101A I20051008RMEP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>25</main-group>
        <subgroup>24</subgroup>
        <classification-value>I</classification-value>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20051008</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="3">
        <text>A01N  47/44        20060101A I20051008RMEP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>47</main-group>
        <subgroup>44</subgroup>
        <classification-value>I</classification-value>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20051008</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="4">
        <text>A01N  59/16        20060101A I20051008RMEP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>59</main-group>
        <subgroup>16</subgroup>
        <classification-value>I</classification-value>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20051008</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="5">
        <text>C02F   1/50        20060101A N20051008RMEP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>C</section>
        <class>02</class>
        <subclass>F</subclass>
        <main-group>1</main-group>
        <subgroup>50</subgroup>
        <classification-value>N</classification-value>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20051008</date>
        </action-date>
      </classification-ipcr>
    </classifications-ipcr>
    <classification-national>
      <country>US</country>
      <main-classification>
        <text>510382000</text>
        <class>510</class>
        <subclass>382000</subclass>
      </main-classification>
      <further-classification sequence="1">
        <text>510131000</text>
        <class>510</class>
        <subclass>131000</subclass>
      </further-classification>
      <further-classification sequence="2">
        <text>510214000</text>
        <class>510</class>
        <subclass>214000</subclass>
      </further-classification>
      <further-classification sequence="3">
        <text>510238000</text>
        <class>510</class>
        <subclass>238000</subclass>
      </further-classification>
      <further-classification sequence="4">
        <text>510383000</text>
        <class>510</class>
        <subclass>383000</subclass>
      </further-classification>
      <further-classification sequence="5">
        <text>510385000</text>
        <class>510</class>
        <subclass>385000</subclass>
      </further-classification>
      <further-classification sequence="6">
        <text>510386000</text>
        <class>510</class>
        <subclass>386000</subclass>
      </further-classification>
      <further-classification sequence="7">
        <text>510390000</text>
        <class>510</class>
        <subclass>390000</subclass>
      </further-classification>
      <further-classification sequence="8">
        <text>510499000</text>
        <class>510</class>
        <subclass>499000</subclass>
      </further-classification>
    </classification-national>
    <classifications-ecla>
      <classification-ecla sequence="1">
        <text>A01N-047/44</text>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>47</main-group>
        <subgroup>44</subgroup>
      </classification-ecla>
      <classification-ecla sequence="2">
        <text>A01N-025/10</text>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>25</main-group>
        <subgroup>10</subgroup>
      </classification-ecla>
      <classification-ecla sequence="3">
        <text>A01N-025/24</text>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>25</main-group>
        <subgroup>24</subgroup>
      </classification-ecla>
      <classification-ecla sequence="4">
        <text>A01N-059/16</text>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>59</main-group>
        <subgroup>16</subgroup>
      </classification-ecla>
    </classifications-ecla>
    <patent-classifications>
      <patent-classification sequence="1">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>A01N-047/44</classification-symbol>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>47</main-group>
        <subgroup>44</subgroup>
        <symbol-position>F</symbol-position>
        <classification-value>I</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20130101</date>
        </action-date>
      </patent-classification>
      <patent-classification sequence="2">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>A01N-025/10</classification-symbol>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>25</main-group>
        <subgroup>10</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20130101</date>
        </action-date>
      </patent-classification>
      <patent-classification sequence="3">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>A01N-025/24</classification-symbol>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>25</main-group>
        <subgroup>24</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20130101</date>
        </action-date>
      </patent-classification>
      <patent-classification sequence="4">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>A01N-059/16</classification-symbol>
        <section>A</section>
        <class>01</class>
        <subclass>N</subclass>
        <main-group>59</main-group>
        <subgroup>16</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20130101</date>
        </action-date>
      </patent-classification>
      <patent-classification sequence="5">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>C02F-001/505</classification-symbol>
        <section>C</section>
        <class>02</class>
        <subclass>F</subclass>
        <main-group>1</main-group>
        <subgroup>505</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>A</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20130101</date>
        </action-date>
      </patent-classification>
      <patent-classification sequence="6">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>C02F-2209/001</classification-symbol>
        <section>C</section>
        <class>02</class>
        <subclass>F</subclass>
        <main-group>2209</main-group>
        <subgroup>001</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>A</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20130101</date>
        </action-date>
      </patent-classification>
      <combination-set sequence="7">
        <group-number>1</group-number>
        <combination-rank>
          <rank-number>1</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-059/16</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>59</main-group>
            <subgroup>16</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>2</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-047/44</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>47</main-group>
            <subgroup>44</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>3</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-025/24</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>25</main-group>
            <subgroup>24</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>4</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-025/10</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>25</main-group>
            <subgroup>10</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
      </combination-set>
      <combination-set sequence="8">
        <group-number>2</group-number>
        <combination-rank>
          <rank-number>1</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-047/44</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>47</main-group>
            <subgroup>44</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>2</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-025/24</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>25</main-group>
            <subgroup>24</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>3</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-025/10</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>25</main-group>
            <subgroup>10</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
      </combination-set>
      <combination-set sequence="9">
        <group-number>3</group-number>
        <combination-rank>
          <rank-number>1</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-047/44</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>47</main-group>
            <subgroup>44</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>2</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-2300/00</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>2300</main-group>
            <subgroup>00</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>A</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
      </combination-set>
      <combination-set sequence="10">
        <group-number>4</group-number>
        <combination-rank>
          <rank-number>1</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-059/16</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>59</main-group>
            <subgroup>16</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>2</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-2300/00</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>2300</main-group>
            <subgroup>00</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>A</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
      </combination-set>
      <combination-set sequence="11">
        <group-number>5</group-number>
        <combination-rank>
          <rank-number>1</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-047/44</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>47</main-group>
            <subgroup>44</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>2</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-025/24</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>25</main-group>
            <subgroup>24</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>3</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-025/10</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>25</main-group>
            <subgroup>10</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
        <combination-rank>
          <rank-number>4</rank-number>
          <patent-classification>
            <classification-scheme office="EP" scheme="CPC">
              <date>20130101</date>
            </classification-scheme>
            <classification-symbol>A01N-025/02</classification-symbol>
            <section>A</section>
            <class>01</class>
            <subclass>N</subclass>
            <main-group>25</main-group>
            <subgroup>02</subgroup>
            <symbol-position>L</symbol-position>
            <classification-value>I</classification-value>
            <classification-status>B</classification-status>
            <classification-data-source>H</classification-data-source>
            <action-date>
              <date>20130101</date>
            </action-date>
          </patent-classification>
        </combination-rank>
      </combination-set>
      <patent-classification sequence="7">
        <classification-scheme office="EP" scheme="ICO"/>
        <classification-symbol>M02F-001/50B</classification-symbol>
      </patent-classification>
      <patent-classification sequence="8">
        <classification-scheme office="EP" scheme="ICO"/>
        <classification-symbol>M02F-209/00B</classification-symbol>
      </patent-classification>
    </patent-classifications>
    <number-of-claims>38</number-of-claims>
    <exemplary-claim>1</exemplary-claim>
    <figures>
      <number-of-drawing-sheets>4</number-of-drawing-sheets>
      <number-of-figures>3</number-of-figures>
      <image-key data-format="questel">US6180584</image-key>
    </figures>
    <invention-title format="original" lang="en" id="title_en">Disinfectant composition providing sustained residual biocidal action</invention-title>
    <references-cited>
      <citation srep-phase="examiner">
        <patcit num="1">
          <text>GOSSELINK EUGENE P, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4165334</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4165334</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="2">
          <text>ELLIS EDWARD J, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5401327</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5401327</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="3">
          <text>SAWAN SAMUEL P, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5490938</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5490938</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="4">
          <text>TRINH TOAN, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5578563</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5578563</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="5">
          <text>SAWAN SAMUEL P, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5681468</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5681468</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="6">
          <text>PALLOS FERENC M, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5776479</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5776479</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="7">
          <text>LUU PHUONG V, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5871763</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5871763</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="8">
          <text>LOWRY MICHAEL RICHARD, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5885562</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5885562</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="9">
          <text>MODAK SHANTA, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5985931</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5985931</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="10">
          <text>GILBERT PETER, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>6004510</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US6004510</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="11">
          <text>SAWAN SAMUEL P, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>6030632</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US6030632</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="12">
          <text>CARL HOROWITZ, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>3050467</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US3050467</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="13">
          <text>MAURER GERALD L, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4055655</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4055655</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="14">
          <text>FOX JR CHARLES L, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4563485</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4563485</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="15">
          <text>FOX JR CHARLES L, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4581028</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4581028</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="16">
          <text>FOX JR CHARLES L, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4612337</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4612337</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="17">
          <text>STOCKEL RICHARD F, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4654208</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4654208</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="18">
          <text>MCDONELL JAMES A, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4783340</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4783340</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="19">
          <text>FOX JR CHARLES L, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5019096</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5019096</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="20">
          <text>OAKES THOMAS R, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5061485</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5061485</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="21">
          <text>LOTH MYRIAM, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5108643</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5108643</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="22">
          <text>OLSTEIN ALAN D</text>
          <document-id>
            <country>US</country>
            <doc-number>5142010</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5142010</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="23">
          <text>GREENWALD RICHARD B, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5158766</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5158766</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="24">
          <text>FOX CHARLES L JR, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5334588</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5334588</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="25">
          <text>HAMILTON JOCK</text>
          <document-id>
            <country>US</country>
            <doc-number>5527506</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5527506</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="26">
          <text>GAUTHIER-FOURNIER FRANCOIS</text>
          <document-id>
            <country>US</country>
            <doc-number>5529713</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5529713</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="27">
          <text>SMITH W NOVIS</text>
          <document-id>
            <country>US</country>
            <doc-number>5576006</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5576006</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="28">
          <text>PATEL VINU, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5585407</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5585407</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="29">
          <text>UNHOCH MICHAEL J, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5668084</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5668084</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="30">
          <text>SAWAN SAMUEL P, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5817325</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5817325</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="31">
          <text>SAWAN SAMUEL P, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5849311</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5849311</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="32">
          <text>SAWAN SAMUEL P, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5869073</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5869073</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="33">
          <text>UNIV COLUMBIA</text>
          <document-id>
            <country>EP</country>
            <doc-number>0328421</doc-number>
            <kind>A2</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-328421</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="34">
          <text>TOKUYAMA SODA KK</text>
          <document-id>
            <country>EP</country>
            <doc-number>0588601</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-588601</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="35">
          <text>KAO CORP</text>
          <document-id>
            <country>EP</country>
            <doc-number>0639636</doc-number>
            <kind>A2</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-639636</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="36">
          <text>SURGIKOS INC</text>
          <document-id>
            <country>GB</country>
            <doc-number>2122900</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>GB2122900</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="37">
          <text>MATSUSHITA ELECTRIC IND CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>S58200884</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP58200884</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="38">
          <text>MITSUBISHI RAYON CO</text>
          <document-id>
            <country>JP</country>
            <doc-number>S618104</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP61008104</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="39">
          <document-id>
            <country>JP</country>
            <doc-number>S63218558</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP63218558</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="40">
          <text>JAPAN IND RES INST, et al</text>
          <document-id>
            <country>JP</country>
            <doc-number>H0268105</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP02068105</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="41">
          <text>TOPPAN PRINTING CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>H02192937</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP02192937</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="42">
          <text>MITSUBISHI RAYON CO</text>
          <document-id>
            <country>JP</country>
            <doc-number>H0365223</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP03065223</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="43">
          <text>FURUKAWA ELECTRIC CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>H04197363</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP04197363</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="44">
          <text>FURUKAWA ELECTRIC CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>H04197362</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP04197362</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="45">
          <text>HITACHI LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>H0470935</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP04070935</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="46">
          <text>FUJI SPINNING CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>H0533217</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP05033217</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="47">
          <text>UNIV COLUMBIA</text>
          <document-id>
            <country>WO</country>
            <doc-number>9004390</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9004390</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="48">
          <text>BIOCOMPATIBLES LTD, et al</text>
          <document-id>
            <country>WO</country>
            <doc-number>9322320</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9322320</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="49">
          <text>BIOPOLYMERIX INC, et al</text>
          <document-id>
            <country>WO</country>
            <doc-number>9517152</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9517152</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="50">
          <text>SURFACINE CONSUMER PRODUCTS, et al</text>
          <document-id>
            <country>WO</country>
            <doc-number>9818330</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9818330</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="1">
          <text>Chemical Abstracts, vol. 127, No. 14 (Oct. 6, 1997).</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="2">
          <text>Davis et al., "Electrode and Bacterial Survival with Iontophoresis in Synthetic Urine", J. Urology, 147:1310-1313 (1992).</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="3">
          <text>Pyle et al., "Efficacy of Copper and Silver Ions with Iodine in the Inactivation of Pseudomonas cepacia", J. Appl. Bact., 72:71-79 (1992).</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="4">
          <text>Quesnel et al., "Synergism Between Chlorhexidine and Sulphadiazine," J. Appl. Bact., 45:397-405 (1978).</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="5">
          <text>Williams et al., "The Biocompatability of Silver", CRC Crit. Rev. Biocompat., 5(3):221-243 (1989).</text>
        </nplcit>
      </citation>
    </references-cited>
    <related-documents>
      <related-publication>
        <document-id>
          <country>US</country>
          <doc-number>60/074456</doc-number>
          <date>19990212</date>
        </document-id>
        <document-id>
          <country>US</country>
          <doc-number>60/074456</doc-number>
          <date>19980212</date>
        </document-id>
      </related-publication>
    </related-documents>
    <parties>
      <applicants>
        <applicant data-format="original" app-type="applicant" sequence="1">
          <addressbook lang="en">
            <orgname>Surfacine Development Company, LLC</orgname>
            <address>
              <address-1>Tyngsboro, MA, US</address-1>
              <city>Tyngsboro</city>
              <state>MA</state>
              <country>US</country>
            </address>
          </addressbook>
          <nationality>
            <country>US</country>
          </nationality>
        </applicant>
        <applicant data-format="questel" app-type="applicant" sequence="2">
          <addressbook lang="en">
            <orgname>SURFACINE DEVELOPMENT</orgname>
          </addressbook>
          <nationality>
            <country>US</country>
          </nationality>
        </applicant>
      </applicants>
      <inventors>
        <inventor data-format="original" sequence="1">
          <addressbook lang="en">
            <name>Sawan, Samuel P.</name>
            <address>
              <address-1>Tyngsboro, MA, US</address-1>
              <city>Tyngsboro</city>
              <state>MA</state>
              <country>US</country>
            </address>
          </addressbook>
          <nationality>
            <country>US</country>
          </nationality>
        </inventor>
        <inventor data-format="original" sequence="2">
          <addressbook lang="en">
            <name>Subramanyam, Sundar</name>
            <address>
              <address-1>Stoneham, MA, US</address-1>
              <city>Stoneham</city>
              <state>MA</state>
              <country>US</country>
            </address>
          </addressbook>
          <nationality>
            <country>US</country>
          </nationality>
        </inventor>
        <inventor data-format="original" sequence="3">
          <addressbook lang="en">
            <name>Yurkovetskiy, Alexander</name>
            <address>
              <address-1>Acton, MA, US</address-1>
              <city>Acton</city>
              <state>MA</state>
              <country>US</country>
            </address>
          </addressbook>
          <nationality>
            <country>US</country>
          </nationality>
        </inventor>
      </inventors>
      <agents>
        <agent sequence="1" rep-type="agent">
          <addressbook lang="en">
            <orgname>Testa, Hurwitz &amp; Thibeault, LLP</orgname>
          </addressbook>
        </agent>
      </agents>
    </parties>
    <examiners>
      <primary-examiner>
        <name>Gupta, Yogendra</name>
      </primary-examiner>
    </examiners>
    <lgst-data>
      <lgst-status>GRANTED</lgst-status>
    </lgst-data>
  </bibliographic-data>
  <abstract format="original" lang="en" id="abstr_en">
    <p id="P-EN-00001" num="00001">
      <br/>
      The present invention relates to a composition that, when applied to a substrate, forms an adherent, transparent, water insoluble polymeric film on the substrate surface that provides sustained antimicrobial disinfecting action for prolonged periods, without the necessity for reapplication.
      <br/>
      The coating provides surface disinfecting action by a contact-killing mechanism, and does not release its components into contacting solutions at levels that would result in solution disinfection.
      <br/>
      The polymeric film formed by the composition of the invention can be removed by treatment with dilute alcoholic base.
    </p>
  </abstract>
  <description format="original" lang="en" id="desc_en">
    <p num="1">
      This application claims benefit of Provisional application Ser.
      <br/>
      No. 60/074456, filed Feb. 12, 1999.
    </p>
    <heading>FIELD OF THE INVENTION</heading>
    <p num="2">
      The present invention relates to a composition that forms an adherent, transparent, water insoluble polymeric film on a substrate surface, and that provides sustained antimicrobial disinfecting action upon contact with microorganisms for prolonged periods, without the necessity for reapplication.
      <br/>
      The coating provides contact-killing surface disinfecting action only, and does not release its components into contacting liquids at levels that would result in solution disinfection.
      <br/>
      The polymeric film of the invention can be easily removed by treatment with dilute alcoholic base.
    </p>
    <heading>BACKGROUND OF THE INVENTION</heading>
    <p num="3">
      The constant threat of bacterial contamination and the associated repercussions on health have made antimicrobial solutions a ubiquitous part of commercial and residential cleaning and disinfection processes.
      <br/>
      Dilute aqueous detergents show no detectable reduction in bacterial levels on surfaces amenable to bacterial growth and proliferation in susceptible environments, such as hospitals and in residential kitchen and bath areas.
      <br/>
      On the other hand, oxidants such as aqueous hypochlorite and phenolic compositions produce substantial reductions in bacterial levels that are relatively short-lived (3 to 6 hours).
      <br/>
      This often results in recontamination due to reuse of such surfaces, requiring frequent reapplication of disinfectant.
      <br/>
      Further, relatively high concentrations of the active agent have to be incorporated in such formulations to obtain broad spectrum disinfection.
      <br/>
      These high concentrations often have undesirable side effects such as skin and eye irritation, in addition to being potentially hazardous when in contact with food.
      <br/>
      There is therefore a need for the development of new disinfecting formulations that can provide sustained broad spectrum microbial disinfection on surfaces over prolonged periods without reapplication, even after being contacted by cleaning solutions and after surface reuse.
      <br/>
      Furthermore, it is desirable to achieve disinfecting action using low levels of the antimicrobial agent that will not pose toxicity problems for the user.
    </p>
    <p num="4">
      The modality of action of film-forming surface sanitizers to date has been solution based, that is, the antimicrobial action is obtained by controlled release via diffusion or dissolution of the active agents into contacting aqueous or volatile solutions.
      <br/>
      Numerous examples of this type of sanitizer have been reported.
      <br/>
      Another typical variant involves hydrolysis or dissolution of the matrix containing an antimicrobial compound, thereby effecting its release into solution.
      <br/>
      High levels of preservatives, however, are also released into contacting solutions in long-term applications.
      <br/>
      In such mechanisms, a bioactive compound is covalently bound either directly to the substrate surface or to a polymeric material that forms a nondissolving surface coating.
      <br/>
      The antimicrobial compounds in such coatings exhibit greatly diminished activity, unless assisted by hydrolytic breakdown of either the bound antimicrobial or the coating itself.
      <br/>
      In either case, relatively high levels of preservative have to be released into solution in order to elicit antimicrobial action.
    </p>
    <heading>SUMMARY OF THE INVENTION</heading>
    <p num="5">
      It is an object of the invention to provide an antimicrobial composition which can be applied to a surface to provide a non-leaching, water-insoluble film which is capable of (i) providing immediate antimicrobial disinfection and antiviral action on the surface, and (ii) providing sustained antimicrobial disinfecting action for prolonged periods after application, even after being contacted by water and aqueous surface cleaners.
      <br/>
      It is also an object of the invention to provide a disinfecting composition that, when applied to a surface, provides a water insoluble film that can be removed from the surface upon application of a non-aqueous, film-dissolving formulation.
      <br/>
      Another object of the invention is to provide a disinfectant composition which further includes an optical reporter, e.g., a fluorophore or an optical brightening agent that enables detection of the composition on a surface by suitable detection devices such as irradiation by an ultraviolet or visible light source.
    </p>
    <p num="6">
      The invention further provides disinfecting compositions that form transparent, adherent, water insoluble films which, when applied on a surface, kill microorganisms contacting the films, but which do not leach or elute significant amounts of antimicrobial components or species into the contacting liquids at levels sufficient to provide disinfection in the contacting solution.
      <br/>
      The antimicrobial composition comprises a combination of an organic biguanide polymer and an antimicrobial metallic material.
    </p>
    <p num="7">
      More particularly, disinfecting compositions of the invention comprise a liquid, gel or foam comprising a solution, dispersion, emulsion or suspension of a polymeric, film-forming material and a metallic biocide in a carrier, which, when applied to a surface, forms a water-insoluble polymeric film on the surface in which the biocide is non-leachably bound to, complexed with, associated with or dispersed.
      <br/>
      The polymeric film forming material preferably comprises a polymer, copolymer or adduct which contains segments that, when the polymer forms a film on a surface, are capable of engaging microorganisms that come in contact with it.
      <br/>
      The biocide preferably is non-leachably attached to, complexed or associated with or dispersed within said film, but is capable of being preferentially transferred directly from the polymeric film to the contacting microorganism due to a higher affinity for proteins within the microorganisms.
    </p>
    <p num="8">
      In one aspect, the composition comprises a combination of (i) an organic polymeric polycationic material which is capable of forming a layer, film or matrix, and (ii) a broad spectrum metallic biocide which, upon application, becomes intercalated in the layer, film or matrix and that interacts sufficiently strongly with the organic material so that the biocide does not dissolve into or elute from the matrix into the surrounding environment.
      <br/>
      The organic material should possess two important properties: it should be capable of reversibly binding or complexing with the biocide, and should be capable of insinuating the biocide into the cell membrane of a microorganism in contact with it.
      <br/>
      The organic material preferably is capable of dissolving into or adhering to the cell membrane surrounding the microorganism.
      <br/>
      Preferred organic materials are those which can be applied on a surface as water-insoluble films and which bind the biocide in such a manner as to permit transfer of the biocide into the microorganism, but will not release the biocide into the surrounding environment, e.g., into the air or into any liquid in contact with the coated surface.
    </p>
    <p num="9">
      The biocide preferably is a low molecular weight metallic material that is toxic to microorganisms and is capable of complexing with or reversibly binding to the organic matrix material, thereby rendering the organic matrix water insoluble.
      <br/>
      The biocide exhibits greater binding affinity for functional groups in cellular proteins of microorganisms.
      <br/>
      When a microorganism contacts the antimicrobial material, the organic material engages or disrupts at least the outer portion of the lipid bilayer of the microorganism's cell membrane sufficiently to permit insinuation of the biocide into the microorganism, where cell proteins or proteins in the lipid bilayer compete effectively for the biocide due to favorable binding constants.
      <br/>
      Stated another way, the metallic material binds to or forms a complex with the organic material in which the association between the organic material and metallic material is sufficiently strong that the layer or film does not elute antimicrobial amounts of the metal into a contacting solution.
      <br/>
      However, the metallic material preferentially binds to certain proteins in the microorganism and thus is transferred from the matrix to the microorganism.
      <br/>
      The result is a contact-killing delivery system that selectively transfers the biocide to or into the microorganism's cell membrane upon contact, without elution or dissolution of the biocide into solution, thereby maintaining the long term antimicrobial efficacy of the composition.
    </p>
    <p num="10">
      The antimicrobial compositions of the present invention are, therefore, molecularly designed to enable a matrix-bound biocide to retain high antimicrobial activity without elution of any compounds into contacting solutions, carriers or other materials.
      <br/>
      The antimicrobial activity stems from the sustained, cooperative biocidal action of its components.
      <br/>
      Selective transfer of one component from within the matrix directly to the microorganism upon contact is achieved via a "hand off" mechanism upon engagement and penetration of the microorganism's cell membrane.
      <br/>
      The antimicrobial material, therefore, maintains long term efficacy without releasing toxic elutables into the surrounding environment.
    </p>
    <p num="11">
      Organic materials useful in the present invention comprise materials which are capable of: (1) adhering to and/or forming a layer or coating on a variety of substrates, (2) reversibly binding or complexing with the biocide, and (3) insinuating the biocide into the cell membrane of the microorganism upon contact.
      <br/>
      A preferred class of materials are those having the aforementioned properties, and which are capable of complexing and/or binding a bactericidal metallic material.
      <br/>
      Most preferred is the class of organic materials having antimicrobial activity.
      <br/>
      For example, a preferred class of materials, polymeric biguanides, form a layer or coating when applied to a substrate.
      <br/>
      The layer or coating can dissolve into, or adhere to, and penetrate at least the outer portion of the lipid bilayer membrane of a microorganism.
      <br/>
      For this purpose, surface active agents, such as cationic compounds, polycationic compounds, anionic compounds, polyanionic compounds, non-ionic compounds, polynonionic compounds or zwitterionic compounds are useful.
      <br/>
      These compounds include, for example, biguanide polymers, or polymers having side chains containing biguanide moieties or other cationic functional groups, such as benzalkonium groups or quarternium groups (e.g., quarternary amine groups).
      <br/>
      The polymer backbone may be any polymer capable of forming a coating on a substrate.
      <br/>
      It is understood that the term "polymer" as used herein includes any organic material comprising three or more repeating units, and includes oligomers, polymers, copolymers, terpolymers, etc.
      <br/>
      The polymer backbone may be a polysilane or polyethylene polymer, for example.
      <br/>
      Organic materials which currently are most preferred for use in the invention are polymeric biguanide compounds.
    </p>
    <p num="12">
      The organic polymeric material may be reacted with a water insoluble organic compound or "hydrophobic agent" in order to increase its water insolubility.
      <br/>
      In a preferred embodiment, the organic material is a polymeric polycationic polymer, which is chemically reacted with a hydrophobic agent to form an adduct.
      <br/>
      The adduct that includes the hydrophobic agent adheres more strongly to certain substrates than the polycationic polymer alone, and exhibits greater water insolubility.
      <br/>
      Hydrophobic agents which can be used in the present invention are organic compounds which are substantially water insoluble and which can react with the polycationic material to form an adduct.
      <br/>
      Suitable hydrophobic agents include, for example, compounds, which may be polymers, containing organic multifunctional groups such as isocyanates, epoxides, carboxylic acids, acid chlorides, acid anhydrides, succimidyl ether aldehydes, ketones, alkyl methane sulfonates, alkyl trifluoromethane sulfonates, alkyl paratoluene methane sulfonates, alkyl halides and organic multifunctional epoxides.
      <br/>
      In a currently preferred embodiment, the organic material comprises an adduct of polyhexamethylene biguanide polymer and an epoxide, such as methylene-bis-N,N-diglycidylaniline, bisphenol-A-epichlorohydrin or N-N-diglycidyl-oxyaniline.
    </p>
    <p num="13">
      The biocidal material can be any antimicrobial material which is capable of non-leachably binding to or complexing with an organic matrix, but which, when placed in contact with the microorganism, preferentially transfers to proteins in the microorganism.
      <br/>
      For this purpose, metallic materials which bind to cellular proteins of microorganisms and are toxic to the microorganisms are preferred.
      <br/>
      The metallic material can be a metal, metal oxide, metal salt, metal complex, metal alloy or mixture thereof.
      <br/>
      Metallic materials which are bactericidal or bacteriostatic and are either substantially water-insoluble or can be rendered water insoluble are preferred.
      <br/>
      By a metallic material that is bacteriostatic or bactericidal is meant a metallic material that is bacteriostatic to a microorganism, or that is bactericidal to a microorganism, or that is bactericidal to certain microorganisms and bacteriostatic to other microorganisms.
      <br/>
      Examples of such metals include, silver, zinc, cadmium, lead, mercury, antimony, gold, aluminum, copper, platinum and palladium, their salts, oxides, complexes, and alloys, and mixtures thereof.
      <br/>
      The appropriate metallic material is chosen based upon the use to which the invention is to be put.
      <br/>
      The preferred metallic materials are silver compounds.
      <br/>
      In a currently preferred embodiment, a silver halide is used, most preferably, silver iodide.
      <br/>
      In another preferred embodiment silver nitrate is used and is converted into a water insoluble silver halide by subsequent chemical reaction with an alkali halide.
      <br/>
      Most preferably, silver nitrate is converted to silver iodide by reacting it with sodium or potassium iodide.
    </p>
    <p num="14">
      The invention comprises compositions for forming a non-leaching antimicrobial layer or coating on a surface.
      <br/>
      In one embodiment, the composition is a sprayable composition comprising a solution, dispersion or suspension of the organic material and the biocidal material.
      <br/>
      Alternatively, the antimicrobial material can be suspended in water or in aqueous solutions containing an organic solvent in the form of an emulsion, microemulsion, latex or colloidal suspension.
      <br/>
      The composition need not be a homogeneous solution.
      <br/>
      If desired, stabilizing agents such as suspending agents or surface active agents may be included.
      <br/>
      If a more hydrophobic coating or film is desired, the solution, dispersion or suspension also may contain the hydrophobic agent.
      <br/>
      As a first step, the hydrophobic agent and the organic material may be reacted to form an adduct in which the hydrophobic agent is covalently linked to the organic polymeric material.
      <br/>
      To form a contact-killing non-leaching coating or layer on a substrate, the disinfectant composition is applied to the substrate, e.g. by wiping, brushing, dipping or spraying, or as an aerosol spray using a suitable propellant, under conditions sufficient to form a layer or film of the polymeric organic material on the substrate.
    </p>
    <p num="15">
      Liquids useful as a liquid carrier for the antimicrobial materials in the present invention include any polar solvent, including water, alcohols such as ethanol or propanol, polar aprotic solvents such as N,N-dimethyl formamide (DMF), N,N-dimethyl acetamide (DMAC), dimethyl sulfoxide (DMSO), dimethyl sulfide (DMS) or N-methyl-2-pyrrolidone (NMP), and mixtures thereof.
      <br/>
      The currently preferred liquid carrier comprises a mixture of ethanol and water.
      <br/>
      In alternative embodiments, the carrier comprises a gel or foam.
    </p>
    <p num="16">
      In the methods of the invention described above, the amounts and/or concentrations of the materials used will depend upon the nature and stoichiometry of the materials used, and the end product desired.
      <br/>
      In the currently preferred embodiments, the total solids concentration of the solution, dispersion or suspension of the sprayable liquid composition typically is in the range of from about 0.1 to about 5% by weight, preferably in the range of 0.2 to 1.0% by weight.
      <br/>
      Typically, an organic material comprising a polymer:hydrophobic agent ratio in the range of from about 1:1 to about 3:1 (weight percent) will form matrices which will non-leachably retain the metallic biocide and preferentially transfer the biocide to the microorganism upon contact, as described herein.
      <br/>
      The concentration of metallic biocide is typically in the range from about 0.001 to about 20% by weight of polymer or polymer-hydrophobic agent adduct in the disinfectant solution composition.
    </p>
    <p num="17">
      In a preferred embodiment, a disinfecting composition according to the present invention is applied as an aerosol spray to form an antimicrobial film or layer on the surface of a substrate.
      <br/>
      In a currently preferred embodiment, the organic matrix is formed by first reacting polyhexamethylenebiguanide with an epoxy, such as methylene-bis-N,N-diglycidylaniline, to form an adduct.
      <br/>
      Stable coating solutions of the resulting adduct have been obtained in both absolute ethanol and in aqueous ethanol.
      <br/>
      The biocidal material, preferably a silver compound, is then added to the adduct solution to form a stable solution or colloidal dispersion or emulsion.
      <br/>
      The resulting mixture is diluted to the desired concentration, then is applied on the substrate surface by spraying.
      <br/>
      Spraying may be carried out, for example, using a standard trigger bottle or other conventional spray applicator, or from a pressurized aerosol can employing a suitable propellant.
      <br/>
      Such suitable propellants include nitrogen, carbon dioxide, hydrocarbon or a hydrocarbon mixture.
      <br/>
      The spray-applied liquid layer may be wiped with a cloth to spread the layer evenly on the substrate.
      <br/>
      Once applied to the substrate, the coating is allowed to dry at ambient temperature, thereby forming a polymeric film on the substrate.
      <br/>
      The resulting film is adherent, optically clear, stable to light and insoluble in aqueous solutions.
      <br/>
      The coating will not wash off with water, soap or most commercial cleaning agents.
      <br/>
      The coating can be removed, if desired, by wiping the coated surface with an alcoholic solution containing a surfactant.
      <br/>
      Examples of alcoholic solutions which can be used include ethanol, aqueous ethanol or isopropanol.
      <br/>
      Examples of surfactants which can be used include, for example, sodium lauryl sulfate or sodium dodecyl sulfate (SDS), sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate, poloxyethylenesorbitan monolaurate (Tween 20), polyethylenesorbitan monopalmitate (Tween 40), polyoxyethylenesorbitan monostearate (Tween 60), polyoxyethylenesorbitan monooleate (Tween 80), polyoxyethylenesorbitan trioleate (Tween 85), or sorbitan monooleate.
      <br/>
      Ethanol solutions containing 0.01 to 5% sodium laurylsulfate, polyoxyethylenesorbitan monopalmitate or sorbitan monooleate are currently most preferred for this purpose.
      <br/>
      The applied film typically is ten microns or less in thickness, although the thickness of the coating may be varied by well-known techniques, such as increasing the solids content of the resin.
    </p>
    <p num="18">
      In another preferred embodiment, the disinfectant composition of the present invention may additionally contain an optical reporter that enables visual detection of presence of the composition on a substrate surface.
      <br/>
      The optical reporting material can be a compound that can be detected spectroscopically and can be a dye, flurophore, optical brightener, pH indicator or thermochromic material.
      <br/>
      Preferred optical reporter materials are optical brightening agents such as 2,2'-(2,5-Thiophenediyl)bis5-tert-butyl-benzoxazole (Uvitex OB) or 4,4'-bis-2-diethylamino-4-(2,5-disulphophenyl-amino)-s-triazinyl-6-amino-stilbene-2,2 '-disulphonic acid, sodium salt (Tinopal) marketed by Ciba-Geigy Corporation, which can be visualized by a UV detector.
    </p>
    <p num="19">
      The disinfectant compositions of the present invention may be used as a hard surface disinfecting agent, e.g. as a hospital and institutional disinfectant, kitchen and bathroom disinfectant, cleaner disinfectant or floor and wall cleaner.
      <br/>
      The disinfectant compositions may also be employed as skin disinfectants, antiseptics, sanitizers, protectants, liquid wound dressings or bandages.
      <br/>
      The disinfectant compositions may be used for treating skin contacting articles, such as diapers, wound dressings, wipes, masks and surgical gowns, and non-body contacting articles, such as hospital bed rails, carpets and rugs.
    </p>
    <p num="20">The above and other objects, features and advantages of the present invention will be better understood from the following specification when read in conjunction with the accompanying drawings.</p>
    <heading>BRIEF DESCRIPTION OF THE DRAWINGS</heading>
    <p num="21">
      FIG. 1A is a schematic graphic illustration of the polymer/biocide complex of the present invention, in a solvent, as applied to a surface.
      <br/>
      FIG. 1B is a schematic graphic illustration of the polymer/biocide complex of the present invention, as applied to a surface, after evaporation of the solvent, leaving a polymer/biocide film on the surface.
      <br/>
      FIG. 1C is a schematic graphic illustration of the contact-killing ability of the film forming matrix/biocide complex of the present invention upon contact of the film with microorganisms, wherein the polymer chains engage and disrupt the microorganism cell membrane.
      <br/>
      FIG. 1D shows penetration of the cell membrane and transfer of the biocide from the network to proteins in the microorganism, causing cell death.
      <br/>
      FIG. 2A is a graph illustrating the immediate (upon application) and sustained (after contacting water) disinfecting efficacy of a film formed from the composition of the invention against S. aureus and E. coli.
      <br/>
      FIG. 2B is a graph illustrating the immediate (upon application) and sustained (after contacting water) disinfecting efficacy of a film formed from the composition of the invention against P. aeruginosa.
      <br/>
      FIGS. 3A and 3B are graphs illustrating the durability of the present antimicrobial coatings after repeated cycles of challenge with P. aeruginosa, incubation and washing.
    </p>
    <heading>DETAILED DESCRIPTION</heading>
    <p num="22">
      The disinfecting composition of the present invention are applied to a variety of substrates to obtain a coating or layer having antimicrobial and antiviral disinfecting action.
      <br/>
      Disinfecting compositions according to the present invention can be applied, for example, to woods, metals, paper, synthetic polymers (plastics), natural and synthetic fibers, natural and synthetic rubbers, cloth, glasses, and ceramics.
      <br/>
      Examples of synthetic polymer substrates include elastically deformable polymers which may be thermosetting or thermoplastic such as, for example, polypropylene, polyethylene, polyvinylchloride, polyethylene terephthalate, polyurethane, polyesters, rubbers such as polyisoprene or polybutadiene, polytetrafluoroethylene, polysulfone and polyethersulfone polymers or copolymers.
      <br/>
      Inorganic materials to which the present coatings can be applied include glass fiber materials, ceramics such as alumina or silica, and metals.
      <br/>
      The present antimicrobial spray also can be applied to and form a coating on sintered glass and sintered ceramic substrates.
    </p>
    <p num="23">The term "microorganism" as used herein includes bacteria, blue-green algae, fungi, yeast, mycoplasmids, protozoa and algae.</p>
    <p num="24">
      The term "biocidal" as used herein means bactericidal or bacteriostatic.
      <br/>
      The term "bactericidal" as used herein means the killing of microorganisms.
      <br/>
      The term "bacteriostatic" as used herein means inhibiting the growth of microorganisms, which can be reversible under certain conditions.
    </p>
    <p num="25">
      As used herein, the terms "non-leachable" and "substantially non-leachable" mean that bio-active components in films obtained by application of the disinfecting compositions do not dissolve, elute, leach or otherwise provide species into a liquid environment in contact with the said films at levels that would result in solution disinfection, that is, in antimicrobially effective amounts.
      <br/>
      Preferably, this threshold is below the minimum solution concentrations of such components to impart solution disinfection.
    </p>
    <p num="26">
      Organic materials useful in the present invention comprise materials which are capable of: (1) adhering to and/or forming a layer or coating on a variety of substrates, (2) reversibly binding to or complexing with the bactericide, and (3) insinuating the bactericide into the cell membrane of the microorganism.
      <br/>
      A preferred class of materials are those having the aforementioned properties, which are capable of being immobilized on a surface and which preferentially bind a biocidal metallic material in such a manner so as to permit release of the metallic biocide to the microorganism, but not to the contacting environment.
      <br/>
      Most preferred is the class of organic materials having antimicrobial properties, that is, materials which, when applied as a coating, can dissolve into, adhere to, disrupt or penetrate the lipid bilayer membrane of a microorganism in contact with the coating.
      <br/>
      In a preferred embodiment, the organic material is a polymer containing segments which, when the polymer forms a coating on a surface, are capable of engaging microorganisms which come into contact with the coating.
      <br/>
      By "engaging" is meant that the coating can attach and temporarily immobilize a microorganism in contact with it.
      <br/>
      For this purpose, surface active agents, such as cationic compounds, polycationic compounds, anionic compounds, polyanionic compounds, non-ionic compounds, polyanionic compounds or zwitterionic compounds may be used.
      <br/>
      Organic materials which currently are most preferred for use in the invention are polymeric biguanide compounds.
      <br/>
      When applied to a substrate, these polymers form a coating on the substrate which can engage and disrupt a microorganism as shown in FIG. 1.
    </p>
    <p num="27">
      Polymeric materials useful in the present invention include benzalkoniumchloride derivatives,  ALPHA -4-1-tris(2-hydroxyethyl) ammonium-2-butenyl poly1-dimethylamnmonium-2-butenyl- OMEGA -tris(2-hydroxyethyl) ammonium chloride.
      <br/>
      Preferred polymeric compounds include polymeric biguanides and their salts of the general formula:  (Chemical Structure image '1' not included in text)
    </p>
    <p num="28">or water soluble salts, where X is any aliphatic, cycloaliphatic, aromatic, substituted aliphatic, substituted aromatic, heteroaliphatic, heterocyclic, or heteroaromatic compound, or a mixture of any of these, and Y1 and Y2 are any aliphatic, cycloaliphatic, aromatic, substituted aliphatic, substituted aromatic, heteroaliphatic, heterocyclic, or heteroaromatic compound, or a mixture of any of these, where n is an integer equal to or greater than 1, and wherein Z is an anion such as Cl- or OH-. The currently most preferred polymeric compound is polyhexamethylene biguanide (available from Zeneca Biocides, Inc. of Wilmington, Del. as a 20% aqueous solution under the trade name COSMOCIL-CQ).</p>
    <p num="29">
      In one embodiment of the present invention, the organic material comprises an organic material which has been reacted with a hydrophobic agent to form an adduct.
      <br/>
      Hydrophobic agents which can be used in the present invention are those which react with the organic material to form the adduct.
      <br/>
      Suitable hydrophobic agents include, for example, organic compounds containing multifunctional groups such as isocyanates, epoxides, carboxylic acids, acid chlorides, acid anhydrides, succimidyl ether aldehydes, ketones, alkyl methane sulfones, alkyl trifluoromethane sulfonates, alkyl paratoluene methane sulfones, alkyl halides and organic multifunctional epoxides.
      <br/>
      In a currently preferred embodiment, a polyhexamethylene biguanide polymer is reacted with an epoxide, such as methylene-bis-N,N-diglycidylaniline.
      <br/>
      The degree of hydrophobicity of the resulting adduct can be adjusted by choice of the hydrophobic agent.
      <br/>
      The organic material can be polymeric or non-polymeric, however the resulting adduct must be capable of forming a coherent film.
    </p>
    <p num="30">
      The biocidal material can be any antimicrobial material which is capable of non-leachably binding to or complexing with the organic matrix, but which, when placed in contact with the microorganism, preferentially transfers to the microorganism.
      <br/>
      For this purpose, metallic materials which are toxic to microorganisms are preferred.
      <br/>
      The metallic material can be a metal, metal oxide, metal salt, metal complex, metal alloy or mixture thereof.
      <br/>
      Metallic materials which are bactericidal or bacteriostatic and are substantially water-insoluble are preferred.
      <br/>
      By a metallic material that is bacteriostatic or bactericidal is meant a metallic material that is bacteriostatic to a microorganism, or that is bactericidal to a microorganism, or that is bactericidal to certain microorganisms and bacteriostatic to other microorganisms.
      <br/>
      Examples of such metals include, e.g., silver, zinc, cadmium, lead, mercury, antimony, gold, aluminum, copper, platinum and palladium, their oxides, salts, complexes and alloys, and mixtures of these.
      <br/>
      The appropriate metallic material is chosen based upon the ultimate use of the device.
      <br/>
      The currently preferred metallic materials are silver compounds.
    </p>
    <p num="31">
      Carriers useful in the present invention include liquids, gels or foams.
      <br/>
      Liquids useful as the liquid carrier for the antimicrobial materials in the present invention include any polar liquid, including water, alcohols such as ethanol or propanol, polar aprotic solvents such as N, N-dimethyl formamide (DMF), dimethyl sulfoxide (DMSO) or N-methyl-2-pyrrolidone (NMP), and mixtures thereof.
      <br/>
      The currently preferred liquid carrier comprises a mixture of ethanol and water.
      <br/>
      The liquid carrier in the present invention can itself be an antimicrobial disinfectant capable of causing immediate disinfection upon application of the formulation on a bacterially contaminated surface, including specially denatured alcohol (SD-alcohol) which is comprised of 95% ethyl alcohol denatured with 5% isopropanol, or pure isopropanol.
    </p>
    <p num="32">The biocidal material can be introduced into the matrix either contemporaneously with or after application of the organic material to a surface.</p>
    <p num="33">
      The amount and/or type of the antimicrobial composition which is used in a particular application will vary depending on several factors, including the type and amount of contamination which is likely to occur, and the size of the antimicrobial surface.
      <br/>
      The amount of antimicrobial used will be a minimum amount necessary to maintain the sterility of the surface.
      <br/>
      As stated above, this amount will vary depending upon various considerations understood by those of ordinary skill in the art.
    </p>
    <p num="34">
      In a preferred embodiment, when the disinfectant composition is applied to a substrate, the organic material forms an insoluble, non-leachable film having a unique configuration: some of the organic material protrudes into the surrounding environment, that is, "arms" or "tentacles" of the organic material project away from the matrix and into the surrounding environment.
      <br/>
      This phenomenon can be understood by referring to FIG. 1, which is a schematic graphic illustration of a preferred embodiment of the present invention in which the organic material is a biguanide polymer reacted with a water insoluble organic compound to increase the water insolubility of the said polymer, and the biocidal metallic material is a silver halide salt, preferably silver iodide.
      <br/>
      FIG. 1A show the polymer film having tentacles projecting into the ambient environment, with the silver salt being present within reservoirs and on the tentacles.
      <br/>
      Without wishing to be bound by any theory, it is believed that when a microorganism contacts the coating, the biguanide polymer tentacles dissolve into the lipid bilayer constituting the organism cell membrane surrounding the microorganism, thereby introducing silver molecules into the interior of the microorganism or to proteins within the cell membrane.
      <br/>
      Silver has a greater binding affinity for certain proteins in the microorganism than for the polymer film, and therefore complexes with the cellular proteins and is transferred into the microorganism, thereby causing protein denaturation within the organism resulting in its death.
      <br/>
      Specifically, it is known that the silver forms complexes with the sulfhydryl and amino groups of the cellular proteins.
    </p>
    <p num="35">
      In this embodiment, the silver salt is attached to or impregnated into the matrix comprising the film and on the tentacles of the polymer such that the silver is substantially non-leachable into the surrounding environment, that is, substantially no silver leaches from the coating into a liquid in contact with the coating.
      <br/>
      This is substantiated by performing the standard Kirby-Bauer zone of inhibition test using test substrates which contain a disinfecting composition.
      <br/>
      The absence of a zone in such tests indicates that bioactive components from the composition do not dissolve, elute, leach or provide species in the contacting medium at levels necessary to cause death.
      <br/>
      Again, not wishing to be bound by any theory, it is believed that the silver salt forms complexes with functional groups in the polymer, and that the complexed silver resists leaching into ambient liquids or other materials (e.g. water, and aqueous solutions including common cleaning liquids) in contact with the treated surface.
      <br/>
      However, when the treated surface becomes exposed to cellular proteins, the silver preferentially complexes with the proteins.
    </p>
    <p num="36">
      In a currently preferred embodiment, the polymeric material is polyhexamethylene biguanide, (PHMB) and the hydrophobic agent is methylene-bis-N,N-diglycidylaniline (MBDGA).
      <br/>
      The preferred silver salt is a silver halide, most preferably, silver iodide or silver nitrate, which is readily converted to a silver halide, most preferably silver iodide.
      <br/>
      In this embodiment, the antimicrobial material is made by combining a solution of polyhexamethylene biguanide with a solution of the hydrophobic agent, and reacting the mixture under conditions sufficient to form a PHMB-MBDGA adduct.
      <br/>
      The ratio of PHMB to MBDGA preferably is in the range of from about 1:1 to 3:1 by weight.
      <br/>
      The concentration of the resulting adduct resin preferably is in the range of from about 0.5 to about 20% by weight.
      <br/>
      The biocidal material, preferably silver iodide, is added to the adduct solution to form the liquid antimicrobial composition.
      <br/>
      Silver solutions having a concentration of from about 0.005 to about 0.5% can be used for this step.
      <br/>
      Silver iodide is currently the most preferred form of the biocidal metallic material.
      <br/>
      It is added either to the adduct solution as such or obtained by adding silver nitrate to the adduct solution and converting it to silver iodide by addition of and alkali metal iodide such as sodium or potassium iodide.
      <br/>
      The silver iodide forms reservoirs in the matrix, and becomes attached to the tentacles.
      <br/>
      Silver iodide has sufficient affinity for the PHMB polymer that it forms an insoluble complex that will not leach into ambient solutions or other materials in contact with the material, even at elevated temperatures.
      <br/>
      However, when a microorganism contacts the film, the tentacles disrupt the microorganism's lipid bilayer membrane, thereby introducing the silver iodide into the microorganism.
      <br/>
      Silver iodide has greater affinity for certain proteins within the microorganism than for the PHMB-MBDGA matrix, and forms complexes with these proteins, that is, the silver is preferentially transferred from the coating to the microorganism.
      <br/>
      The silver accumulates to toxic levels in the microorganism and kills it.
      <br/>
      The silver iodide reservoirs within the matrix replenish the silver iodide on the tentacles lost to the microorganism by reestablishing the equilibrium for formation of the complex
      <br/>
      (AgI+PHMB (reversible reaction) PHMBAgI).
    </p>
    <p num="37">
      The present invention provides stable disinfectant compositions which can be used to apply adherent antimicrobial films or layers onto a wide range of materials, including those commonly used in membranes, medical device manufacture, hospitals, laboratories, kitchens and bathrooms.
      <br/>
      The antimicrobial films or layers are capable of providing sustained disinfection action for prolonged periods .
      <br/>
      In a preferred embodiment, the liquid composition is a sprayable formula which can be spray-applied directly to most surfaces without prior surface modification.
    </p>
    <p num="38">
      Surfaces treated with the disinfectant composition according to the present invention exhibit (i) immediate antimicrobial disinfection activity against both gram positive and gram negative bacteria and yeast, and are resistant to fungal growth, and (ii) instant antiviral activity.
      <br/>
      Treated surfaces completely kill organisms at challenge levels of 106 -108 CFU/mL within 8 to 20 hours at 30 (degree)  C., depending on organism type.
      <br/>
      The treated surfaces inactivate viruses such as poliovirus, hepatitis-B and rhinovirus.
      <br/>
      Additionally, the disinfectant composition according to the present invention exhibits antimicrobial disinfection activity for prolonged periods after its application, even after being contacted with water and aqueous cleaner solutions such as soaps and shampoos.
    </p>
    <p num="39">
      The antimicrobial composition of the present invention can be applied to a surface to form contact-killing coatings or layers on a variety of substrates.
      <br/>
      As shown in the Examples, the material forms a non-leaching contact-killing surface on surfaces such as ceramic tiles, fiberglass or enamel, synthetic countertops, chrome fixtures, shower curtains, mirrors and other clinical or home areas where microbial contamination is a concern.
    </p>
    <p num="40">
      For example, surfaces in medical offices or hospitals, such as treatment tables or consoles in a typical dental office, have proven to be a major source of bacterial contamination-posing potential health risks to the patients and staff.
      <br/>
      Coating or treating these surfaces with the antimicrobial materials of the present invention can reduce or prevent microbial contamination on these substrates.
      <br/>
      In the home, surfaces in kitchens and bathrooms, including bathroom fixtures, countertops, mirrors, and accessories (e.g., shower curtains) can be treated with the present composition to reduce or eliminate microbial contamination.
    </p>
    <p num="41">
      The present antimicrobial materials have been tested against the bacteria most commonly found in water (see Examples below).
      <br/>
      Treated ceramic tiles withstood repeated attempts to introduce microbial contamination at very high challenge levels, while untreated control tiles developed extensive bio-films.
    </p>
    <p num="42">
      The present composition forms a long lasting, optically clear, non-streaking coating or layer on the surface to which it is applied.
      <br/>
      The coating can not be washed off with water, soap or most commercially available cleaning products formulated for use in the kitchen or bath.
      <br/>
      The coating can be removed by wiping the coated surface with an acidic, alkaline or alcoholic solution, for example, with aqueous ethanol, isopropanol or mixture thereof
    </p>
    <p num="43">The invention is further illustrated by the following examples, which are not intended to be limiting in any way.</p>
    <heading>EXAMPLES</heading>
    <p num="44">
      All examples consist of adduct resins obtained by reaction of polyhexamethylenebiguanide hydrochloride salt (PHMB.HCl) or polyhexamethylenebiguanide free base (PHMB) with bifunctional or multifunctional epoxides.
      <br/>
      Epoxides used in the present invention include methylene-bis-N,N-diglycydyl aniline (MBDGA) sold as Araldite MY-720 by Ciba Resins; bisphenol A epichlorohydrin (Average molecular weights ranging from 400 to 1700) (Aldrich Chemical Company); or N,N-diglycidyl-4-glycidyloxyaniline (Aldrich Chemical Company).
      <br/>
      The ratio of PHMB (base) or PHMB.HCl to epoxide is from about 2:1 to 1:1 (wt:wt ratio).
    </p>
    <p num="45">Example 1</p>
    <p num="46">Preparation of PHMB Solutions</p>
    <p num="47">Example 1A</p>
    <p num="48">
      To a stirred solution of 160 ml of PHMB.HCl solution (20 wt % aqueous solution sold as Cosmocil CQ by Zeneca Biocides, Wilmington, Del.), a solution containing 20 g of methylene-bis-N,N-diglycidylaniline (MBDGA) (Ciba Resins, Hawthorne, N.J.) dissolved in 100 mL N,N-dimethylformamide (DMF) and 130 mL ethanol, was added dropwise.
      <br/>
      The reaction mixture was refluxed with stirring for 1 hour during which time the initially turbid solution turned clear.
      <br/>
      The solution was allowed to cool to room temperature to give the adduct resin as a 20% wt solids.
      <br/>
      This solution was diluted appropriately with absolute alcohol.
    </p>
    <p num="49">Example 1B</p>
    <p num="50">
      To a stirred solution of 32.5 mL of PHMB base in ethanol (prepared by addition of NaOH solution to aqueous PHMB.HCL followed by filtration drying and redissolution in ethanol) containing 13% solids by weight, 32.5 g of bisphenol-A epichlorohydrin (ave. mol. wt.=1075) dissolved in 77 mL of DMF was added rapidly with stirring.
      <br/>
      The reaction mixture was refluxed with stirring for 1 hour during which time the initially turbid solution turned clear.
      <br/>
      The solution was allowed to cool to room temperature to give the adduct resin as a 20% wt solids.
      <br/>
      This solution was diluted appropriately with absolute alcohol.
    </p>
    <p num="51">Example 1C</p>
    <p num="52">
      To a stirred solution of 130 mL of PHMB.HCL solution (20 wt % aqueous solution sold as Cosmocil CQ by Zeneca Biocides) was added 70 mL of deionized water followed by a solution containing 17.3 g of N,N-diglycidyl-4-glycidyloxyaniline (Aldrich Chemical Company) dissolved in 25 mL N,N-dimethylformamide (DMF) and 130 mL ethanol was added dropwise.
      <br/>
      The reaction mixture was refluxed with stirring for 2 hours during which time the initially turbid solution turned clear.
      <br/>
      The solution was allowed to cool to room temperature to give the adduct resin as a 20% wt solids.
      <br/>
      This solution was diluted appropriately with absolute alcohol.
    </p>
    <p num="53">Example 2</p>
    <p num="54">Preparation of Sprayable Antimicrobial Compositions</p>
    <p num="55">Four different formulations were prepared:</p>
    <p num="56">
      1.
      <br/>
      Example 2A, Formulation ATT1: contained PHMB.HCL and AgI as the active ingredients; formulated as an antimicrobial coating for polar plastics, cellulosics and metals; applied from organic solvent based solutions.
    </p>
    <p num="57">2. Example 2B, Formulation ATT2: contained PHMB.HCL and AgI as the active ingredients; formulated as a general purpose antimicrobial coating; applied from aqueous ethanol based solutions.</p>
    <p num="58">3. Example 2C, Formulation ATT3: contained PHMB.HCL/epoxy copolymer and AgI as the active ingredients; formulated as a general purpose antimicrobial coating; applied from aqueous ethanol based solutions.</p>
    <p num="59">4. Example 2D, Formulation ATT4: contained PHMB.HCL/epoxy copolymer and AgI as the active ingredients; formulated as a general purpose antimicrobial coating; applied from aqueous solutions with a water content of more than 90%.</p>
    <p num="60">Example 2A</p>
    <p num="61">Formulation ATT1</p>
    <p num="62">
      20g of Cosmocil CQ (Zeneca, Biocides, Wilmington, Del.) 4 g of silver iodide (AgI) 2 g of potassium iodide (KI) and 80 ml of N,N-dimethylformamide (DMF) were mixed together in a flask for 15 minutes.
      <br/>
      The volume of obtained solution (light yellow color) was adjusted with DMF to 100 ml.
      <br/>
      The resulting solution contained 10% (w/v) of solids.
      <br/>
      Prior to application, stock solution was 10-fold diluted with 1:1 (v/v) mixture of DMF and ethanol to a final solids content of 1% (w/v).
    </p>
    <p num="63">Example 2B</p>
    <p num="64">Formulation ATT2</p>
    <p num="65">
      20 g of Cosmocil CQ, 2.8 g of sodium dodecyl sulfate (SDS), 1.3 g of AgI, 0.4 g of KI and 25 ml of DMF, 20 ml N-methyl-2-pyrrolidone (NMP) and 20 ml of ethanol were mixed together in a flask for 30 minutes.
      <br/>
      The volume of obtained stock solution (yellow-brown color) was adjusted with ethanol to 100 ml.
      <br/>
      Prior to application, the stock solution was diluted with 70% (v/v) aqueous ethanol to a solids content of 0.5% (w/v).
    </p>
    <p num="66">Example 2C</p>
    <p num="67">Formulation ATT3</p>
    <p num="68">
      20 g of Cosmocil CQ was mixed with 25 ml of DMF solution containing 5 g of Araldite 720 epoxy resin as described in Example 1A.
      <br/>
      The resulting slurry was heated to 95-98 (degree)  C. After 30 minutes of agitation at this temperature, the clarified solution was cooled down and filtered.
    </p>
    <p num="69">
      Then 40 ml of obtained solution, 2.8 g of sodium dodecyl sulfate (SDS), 1.3 g of AgI, 0.4 g of KI, 5 ml of DMF, 20 ml of ethanol and 20 ml of NMP were mixed together in a flask for 30 minutes.
      <br/>
      The volume of obtained stock solution (yellow-brown color) was adjusted with ethanol to 100 ml.
      <br/>
      Prior to application the stock solution was diluted with 70% (v/v) aqueous ethanol to a final solids content of 0.5% (w/v).
    </p>
    <p num="70">Example 2D</p>
    <p num="71">Formulation ATT4</p>
    <p num="72">
      25 g of Cosmocil CQ was mixed with 25 ml of a DMF solution containing 5 g of bisphenol A epichlorhydrin epoxy resin, average molecular weight 480 (obtained from Aldrich Chemical Co., Milwaukee, Wis.) as described in Example 1B.
      <br/>
      The resulting slurry was heated to 95-98 (degree)  C. After 30 minutes of agitation at this temperature, the clarified solution was cooled down and filtered.
    </p>
    <p num="73">
      40 ml of the obtained solution, 2 g of AgI and 0.6 g of KI, 2.5 g of polyvinyl pyrrolidone (PVP) (average MW 29000, obtained from Aldrich, Milwaukee, Wis.), 20 ml of ethanol and 20 ml of distilled water were mixed together in a flask for 30 minutes.
      <br/>
      The volume of obtained stock solution (colorless) was adjusted with water to 100 ml.
      <br/>
      Prior to application, the stock solution was diluted with deionized water to get final solids content of 0.5% (w/v).
    </p>
    <p num="74">Example 2E</p>
    <p num="75">Formulation S1 and S3</p>
    <p num="76">
      To 227 ml of a 12.9% PHMB-MBGDA adduct solution in ethanol was added 12.6 g of sodium lauryl sulfate (Aldrich Chemical Company, Milwaukee, Wis.) dissolved in a mixture containing 30 ml of water and 30 ml of ethanol, with agitation.
      <br/>
      To this was added 2.1 g of silver nitrate added in a mixture containing 30 ml of water and 30 ml of ethanol.
      <br/>
      The resulting solution was diluted with 542 ml of ethanol and 51 ml of N-methyl-2-pyrrolidone with agitation.
      <br/>
      This solution was combined with a solution containing 3.1 g potassium iodide in a mixture of 30 ml of water and 30 ml of ethanol.
      <br/>
      The mixture was agitated for 1 hour after which the resulting solution was filtered through 5 micron filter.
      <br/>
      The resultant emulsion is diluted as necessary to obtain the liquid disinfectant in the use concentration.
    </p>
    <p num="77">Example 3</p>
    <p num="78">Coating Application</p>
    <p num="79">
      The coatings described in Example 2 were applied by spraying over the surface of ceramic tiles (using a standard 22-oz trigger bottle) and spreading the liquid evenly with a soft tissue.
      <br/>
      One square foot of a tile surface was treated at once (64 tiles, each 35mm x 35 mm in size).
      <br/>
      Alcohol based formulations were dried for 10 minutes, and aqueous or DMF based formulations were dried for 30 minutes.
    </p>
    <p num="80">Antimicrobial activity testing</p>
    <p num="81">The coated samples were tested for antimicrobial efficacy in the following tests (results shown in Table 1):</p>
    <p num="82">
      A.
      <br/>
      Standard bactercidal test for hospital grade disinfectant;
      <br/>
      B.
      <br/>
      Standard fungicidal test for hospital grade disinfectant;
      <br/>
      C.
      <br/>
      Standard virucidal test for hospital grade disinfectant;
      <br/>
      D.
      <br/>
      Residual efficacy test for disinfectant;
      <br/>
      E.
      <br/>
      Multiple microbial challenge test for sustained residual disinfection--results shown below;
      <br/>
      F.
      <br/>
      Antimicrobial efficacy of the coating after one exposure to common bathroom cleaning solutions--results shown in Example 8;
      <br/>
      G.
      <br/>
      Coating antimicrobial efficacy in the presence of growth supporting media--results (not shown) indicated no growth on the coated tiles; and
      <br/>
      H.
      <br/>
      Kirby-Bauer zone of inhibition test--results (not shown) did not show a zone of inhibition, indicating that the coatings were non-leachable.
    </p>
    <p num="83">A-C. Standard tests for bacterial, viral andfungicidal activity</p>
    <p num="84">Tests were run with S3 formulation per American Society of Analytical Chemists (AOAC) protocols.</p>
    <p num="85">
      Formulation was applied to glass slides that were subjected to bacterial, fungal and viral challenge per standard test conditions.
      <br/>
      The formulation was disinfecting, virucidal and fungicidal under these test conditions.
      <br/>
      The efficacy data are summarized in Table 1 (1a-c).
    </p>
    <p num="86">D. Sustained residual disinfection testing</p>
    <p num="87">Tests were done on residual film obtained from S3 formulation on glass slides and ceramic tiles after evaporation of solvents.</p>
    <p num="88">
      The residue was immersed in water at 25 (degree)  C. for 24 hours, after which it was challenged with Psedomonas aeruginosa, Staphylococcus aureus and Salmonella choleraseius.
      <br/>
      Tiles and slides containing residue after water contact were inoculated with 0.3 ml of a microorganism suspension in PBS.
      <br/>
      Incubation of microorganisms was carried out at ambient temperature (20 (degree)  C.) in a humidity chamber.
      <br/>
      Planctonic microorganisms were recovered from the tile surface, then serial dilutions were performed and plate counted by standard techniques.
      <br/>
      The reduction in the microorganism count compared to control tiles is reported in Table 1d .
    </p>
    <p num="89">E. ATT coating performance in multiple microbial challenge test</p>
    <p num="90">Nonporous glazed tiles, 35 * 35 mm size, treated with the ATT formulations were tested for antimicrobial efficacy in a multiple challenge test with gram negative bacteria Pseudomonas aeruginisa and Escherichia coli; gram positive bacteria, Staphylococcus aureus; fungus Aspergillus niger (mold); and Candida albicans (yeast).</p>
    <p num="91">
      Tiles were repetitively inoculated with 0.3 ml of a microorganism suspension in PBS.
      <br/>
      Between the inoculations the tile samples were rinsed with tap water (250 ml per tile) and air-dried.
      <br/>
      No sterilization of the samples was performed between inoculation cycles.
      <br/>
      Incubation of microorganisms was carried out at ambient temperature (20 (degree)  C.) in a humidity chamber.
      <br/>
      Planctonic microorganisms were recovered from the tile surface, then serial dilutions were performed and plate counted by standard techniques.
      <br/>
      The reduction in the microorganism count compared to control tiles is reported in Table 2.
    </p>
    <p num="92">
      -- TABLE 1
      <br/>
      --  ANTIMICROBIAL EFFICACY OF DISINFECTANT FORMULATION
      <br/>
      -- I. Initial Efficacy of Surfacine Disinfectant Spray
      <br/>
      -- Table 1 a. Germicidal Efficacy of Disinfectant Formulation
      <br/>
      --
      <br/>
      --         Organism
      <br/>
      --                                                  Replicates
      <br/>
      --          Recovery
      <br/>
      --                     Test                 ATCC    w/out soil with soil
      <br/>
      --  Antimicrobial cfu/sample        Reduction
      <br/>
      -- Claim       Batch*  Mode   Organism      -   load      load      Time To
      <br/>
      --  Act   Control   Test   Percentage Log10  Remarks
      <br/>
      -- Hospital    S3  *  16 Spray  P. aeruginosa 15442   30        *40
      <br/>
      --  10 minutes    106  0      99.9999   6      1 soil
      <br/>
      -- Disinfectant                S. aureaus     6538 20        10        10
      <br/>
      --  minutes    106  0      99.9999   6      sample
      <br/>
      --                            S. choleraesuis 10702   20        10        10
      <br/>
      --  minutes    106  0      99.9999   6      tested
      <br/>
      --
      <br/>
      --                                           positive for
      <br/>
      --
      <br/>
      --                                           presence*
      <br/>
      -- *Data represents 5 batches
      <br/>
      -- Table 1 b. Virucidal Efficacy of Disinfectant Formulation
      <br/>
      --                   Test                         ATCC
      <br/>
      --  Antimicrobial Soil   Replicate Log10
      <br/>
      -- Claim     Batch   Mode   Virus          Type   -     Strain    Time To Act
      <br/>
      --   Load   -     Reduction Remarks
      <br/>
      -- Virucidal S1  *  16 Spray  Poliovirus     1      VR-1000   Brunhilde 10
      <br/>
      --  minutes    Yes    4         5.5       Complete Inactivation
      <br/>
      -- Activity  S1  *  16        Herpes Simplex 1      VR-733  F(1)      10
      <br/>
      --  minutes    Yes    4         5         Complete Inactivation
      <br/>
      --                          Virus
      <br/>
      --           S1  *  16        Rhinovirus     37     VR-1147   151-1     10
      <br/>
      --  minutes    Yes    4         4         Complete Inactivation
      <br/>
      --           S3  *  16        Hepatitis A           VR-1073   HM-175    10
      <br/>
      --  minutes    Yes    4         3         Complete Inactivation
      <br/>
      -- Table 1 c. Fungicidal Efficacy of Disinfectant Formulation
      <br/>
      --
      <br/>
      --      Organism
      <br/>
      --                                                 Replicates with
      <br/>
      --       Recovery
      <br/>
      --                   Test                  ATCC    w/out soil soil
      <br/>
      --  Antimicrobial cfu/sample         Reduction
      <br/>
      -- Claim     Batch*  Mode    Organism      -   load      load    Time To Act
      <br/>
      --  Control   Test    Percentage Log10  Remarks
      <br/>
      -- Fungicidal S3  *  16 Spray   Trichophyton  9533    0         10      10
      <br/>
      --  minutes    105  0       99.999    5      Complete
      <br/>
      --                           mentagrophytes
      <br/>
      --                                          Inactivation
      <br/>
      -- II.
      <br/>
      Sustained Residual Disinfection Efficacy of Disinfectant Formulation
      <br/>
      -- Table 1 d. Sustained Residual Disinfection Efficacy of Disinfectant
      <br/>
      --  Formulation
      <br/>
      --
      <br/>
      --               Organism
      <br/>
      --
      <br/>
      --   Anti-       Recovery
      <br/>
      --                          Test                    ATCC
      <br/>
      --   microbial   cfu/mL            Reduction
      <br/>
      -- Claim            Batch   Mode      Organism      -   Substrate Replicates
      <br/>
      --  Time To Act Control   Test    Percentage log10 **
      <br/>
      -- Sustained Redidual S3  *  16 24 hours  P. aeruginosa 15442   HDPE
      <br/>
      --  50        20 Hours    106  0       99.999    5
      <br/>
      -- Disinfection             after                   15442   glass     32
      <br/>
      --   20 Hours    105  0       99.99     4
      <br/>
      --                          spray and S. aureus      6533 glass      3   20
      <br/>
      --  Hours    104  0       99.9      4
      <br/>
      --                          water
      <br/>
      --                          contact
      <br/>
      -- Treated HDPE samples (after drying) were contacted with 14 mL/cm2 of
      <br/>
      --  deionized water for 24 hours at room temperature (Protocol IB-M0009-H)
      <br/>
      -- Treated glass slides were rinsed with 5 mL DI water/slide (Protocol
      <br/>
      --  IB-M009-G)
      <br/>
      -- Data represents 4 batches of end use formulation.
      <br/>
      -- *Attributed to non-uniform coverage of substrate surface during application
      <br/>
      --  procedure.
      <br/>
      -- **Log reduction based on sensitivity of plating technique
    </p>
    <p num="93">
      -- TABLE 2
      <br/>
      -- Antimicrobial Efficacy of Spray Coating in Repetitive Challenge Experiments
      <br/>
      --  Involving 10 Cycles
      <br/>
      --                              microorganism count reduction compare to
      <br/>
      --  control, % reduction
      <br/>
      -- Coating   Organism    Incubation cycle 1 Cycle 2 cycle 3 Cycle 4 cycle 5
      <br/>
      --  cycle 6 cycle 7 cycle 8 cycle 9   cycle 10
      <br/>
      -- ATT2      E. coli     20 h. RT  99.999  99.997  99.99   99.997  99.998
      <br/>
      --  99.999  99.998  99.999  99.998    99.997
      <br/>
      --           PSA         20 h. RT  99.998  99.999  99.999  99.999  99.999
      <br/>
      --  99.999  99.999  99.999  99.999    99.999
      <br/>
      --           S. aureaus  20 h. RT  99.9    99.97   98      60      99.9    90
      <br/>
      --      99.9    99.8    99.96     99.5
      <br/>
      --           C. albicans 24 h. RT  99.4    99.4    99.998  99.98   99.996  52
      <br/>
      --      91      10
      <br/>
      --           PSA*        20 h. RT  99.999  99.98   99.999  99.999  99.95
      <br/>
      --  99.99   99.99   99.98   99.8      99.9
      <br/>
      -- ATT2      E. coli     20 h. RT  99.999  99.997  89.999  99.997  89.998
      <br/>
      --  99.999  99.99   99.9    99.998    99.997
      <br/>
      -- after     PSA         20 h. RT  99.998  99.999  99.999  99.999  99.999
    </p>
    <p num="94">
      --  99.999  99.999  99.999  99.998    99.999
      <br/>
      -- water     S. aureaus  20 h. RT  99.95   99.97   99.8    90      89      67
      <br/>
      --      99.95   99.8    99.95     99.8
      <br/>
      -- extraction C. albicans 20 h. RT  99.994  99.8    97      99      60      77
      <br/>
      --       77      0
      <br/>
      -- ATT4      E. coli     20 h. RT  99.997  99.99   99.99   99.99   99.99
      <br/>
      --  99.993  99.8    99.992  96        91
      <br/>
      -- after     PSA         20 h. RT  99.997  99.99   99.99   99.99   99.998
      <br/>
      --  99.998  99.6    99.998  92        83
      <br/>
      -- water     S. aureaus
      <br/>
      -- extraction C. albicans
    </p>
    <p num="95">Example 4</p>
    <p num="96">Contact Test for Biocidal Activity</p>
    <p num="97">Ceramic tiles were spray-coated with the composition described in Example 2B according to the procedure described in Example 3.</p>
    <p num="98">The surface biocidal activity was tested according to the following procedure:</p>
    <p num="99">
      Cultures were prepared of the following microorganisms:
      <br/>
      Escherichia coli (ATCC -8739)
      <br/>
      Pseudomonas aeruginosa (ATCC -9027)
      <br/>
      Salmonella cholerasius (ATCC -10708)
      <br/>
      Staphylococcus aureus (ATCC -6538)
      <br/>
      Candida albicans (ATCC -9642)
      <br/>
      Aspergillus niger (ATCC -9027)
    </p>
    <p num="100">
      Inoculi were prepared from cultures of these microorganisms according to known procedures.
      <br/>
      To test the antimicrobial efficacy of the present coatings, ceramic tiles treated with the coatings and untreated control tiles were sprayed with 106 cfu/ml (cfu=colony forming units) of each of the above organisms.
      <br/>
      The tiles were incubated for 20 hours in a 25 (degree)  C. humidity chamber.
      <br/>
      The number of viable organisms on the surface then was determined by swabbing the surfaces of the tiles and culturing the organisms collected from the surface by the spread plate method.
      <br/>
      The presence of the two fungus samples (Candida and A. niger) also were determined by the turbidity method on PBS extracted swabs.
      <br/>
      The control tiles showed 104 to 106 cfu/ml.
      <br/>
      The treated tiles showed no viable organisms.
    </p>
    <p num="101">Example 5</p>
    <p num="102">Efficacy After Exposure to Water</p>
    <p num="103">
      The ceramic tiles coated with the composition described in Example 4 were further tested to determine antimicrobial efficacy after washing.
      <br/>
      To simulate long-term use, the tiles were washed with tap water for 2 hours. (total volume, 1 gal/in2).
      <br/>
      The biocidal and antifungal challenge tests described in Example 4 were repeated.
      <br/>
      After incubation for 20 to 72 hours, the control tiles showed 104 to 106 cfu/ml bacterial counts and 105 to 106 cfu/ml mold counts.
      <br/>
      Tiles coated with the composition of the invention showed no viable organisms.
    </p>
    <p num="104">Example 6</p>
    <p num="105">Kinetics of Bactericidal Activity</p>
    <p num="106">
      Ceramic tiles were sprayed with the compositions described in Example 2 according to the procedures described in Example 3.
      <br/>
      Some of the sprayed tiles and unsprayed controls were placed under running tap water for 2 hours (total volume, 1 gal/in2) of the following organisms: P. aeruginosa, S. aureus and E. coli.
      <br/>
      The tiles were incubated at ambient temperatures, and the number of viable organisms was determined quantifiably by the spread plate method at different time points.
      <br/>
      The pre- and post-washed spray antimicrobial efficacy was determined as a function of time.
      <br/>
      The results, illustrated in FIGS. 3A and 3B, show that the treated tiles completely eliminated microorganisms from the surface within 10 minutes, whereas the untreated tiles showed no reduction.
    </p>
    <p num="107">Example 7</p>
    <p num="108">Efficacy After Repetitive Challenge</p>
    <p num="109">
      Ceramic tiles sprayed with the coating as described in Example 6 and untreated control tiles were challenged with 105 cfu/ml P. aeruginosa.
      <br/>
      The tiles were incubated at 30 (degree)  C. for 3 hours or for 20 hours in a humidity chamber, after which the presence of viable organisms was determined by the spread plate method.
      <br/>
      The tiles were rinsed with water (250 ml/tile) and the bacterial challenge was repeated.
      <br/>
      This cycle was repeated to obtain a total of 10 challenges each for the 3 hour and 20 hour incubations.
      <br/>
      The results, illustrated in FIGS. 4A and 4B, show that even after 10 repeated washes and bacterial challenges, the tiles treated with the present composition were free of microbial contamination.
    </p>
    <p num="110">Example 8</p>
    <p num="111">Efficacy of Antimicrobial Coating After Exposure to Cleaning Agents</p>
    <p num="112">
      Ceramic tiles were sprayed with the coating described in Example 2B according to the procedure described in Example 3.
      <br/>
      The coated tiles (indicated in Table 2 below as "Treated") and unsprayed control tiles were exposed to various cleaning agents for 2 minutes, rinsed with 100 ml of tap water and air dried.
      <br/>
      The tiles then were inoculated with 106 cfu/ml of P. aeruginosa, and incubated for 20 hours at 30 (degree)  C. in a humidity chamber, then tested for the presence of microbes.
      <br/>
      The results, shown in Table 2 below, indicated that the cleaning agents did not affect the antimicrobial efficacy of the coating.
    </p>
    <p num="113">
      --      TABLE 2
      <br/>
      --                                Control Tiles
      <br/>
      --      Cleaning Agent            (cfu/mL)    Treated Tiles
      <br/>
      --      No cleaning agent         7.70  *  105  0
      <br/>
      --      Soap                      2.80  *  106  0
      <br/>
      --      Shampoo                   2.20  *  107  0
      <br/>
      --      Alconox Detergent         3.00  *  107  0
      <br/>
      --      All purpose Cleaning Solution 1.00  *  106  0
      <br/>
      --      Lysol Bathroom Cleaner    8.10  *  105  0
    </p>
    <p num="114">Example 9</p>
    <p num="115">Alcohol based disinfectant spray formulation incorporating modified biguanide</p>
    <p num="116">
      The preparation of alcohol based disinfectant formulation was carried out in three steps.
      <br/>
      1. Preparation of Poly(hexamethylene) biguanide (PHMB)-Epoxide (Ep) resin
      <br/>
      2.
      <br/>
      Preparation of spray concentrate.
      <br/>
      3. Preparation of disinfectant spray.
    </p>
    <p num="117">Step 1: Preparation of PHMB-Ep resin:</p>
    <p num="118">The PHMB-Ep resin was prepared as described in Example 1A.</p>
    <p num="119">Step 2: Preparation of spray concentrate:</p>
    <p num="120">Spray concentrate was prepared as follows:</p>
    <p num="121">
      --
      <br/>
      --        Component                   Amount, in grams
      <br/>
      --        BG-Ep resin                 465.0
      <br/>
      --        Sodium dodecyl sulfate (SDS) 31.48
      <br/>
      --        Silver nitrate (AgNO3) 5.24
      <br/>
      --        Potassium iodide (KI)       7.90
      <br/>
      --        1-Methyl-2-pyrrodilinone (NMP) 122.00
      <br/>
      --        Water                       210.70
      <br/>
      --        Ethanol                     1158.72
    </p>
    <p num="122">
      The BG-Ep resin was put in a 4-liter Erlenmeyer flask.
      <br/>
      Aqueous alcoholic solutions of SDS, KI and AgNO3 and NMP were introduced with stirring.
      <br/>
      The entire solution was allowed to stir for a period of 2 hours to ensure uniform mixing and then filtered through a Whatman -4 filter paper and stored in appropriate package.
    </p>
    <p num="123">Step 3: Preparation of disinfectant spray:</p>
    <p num="124">Disinfectant spray was prepared as follows:</p>
    <p num="125">
      --
      <br/>
      --        Component                 Amount, in grams
      <br/>
      --        Ethanol                   1480.61
      <br/>
      --        Water                      393.58
      <br/>
      --        Spray Concentrate (from Step 2)  126.36
    </p>
    <p num="126">
      To a four liter Erlenmeyer flask 1480.5 g of ethanol and 393.5 g of water was added.
      <br/>
      The solution was allowed to mix for at least 10 minutes prior to the addition of spray concentrate.
      <br/>
      The spray concentrate was added dropwise over a period of 20-25 minutes with vigorous agitation.
      <br/>
      After completion of addition, the solution was stirred for one hour at the same rate and room temperature.
      <br/>
      After which the solution was filtered through a Whatman -4 filter paper and stored appropriately.
    </p>
    <p num="127">Example 10</p>
    <p num="128">Alcohol based disinfectant spray formulation incorporating modified biguanide</p>
    <p num="129">
      An alternative method of preparation of alcohol based disinfectant formulation was performed involving two steps without passing through a spray concentrate step.
      <br/>
      1. Preparation of Poly(hexamethylene) biguanide (PHMB)-Epoxide (Ep) resin.
      <br/>
      2. Preparation of disinfectant spray.
    </p>
    <p num="130">Step 1: Preparation of PHMB-Ep resin:</p>
    <p num="131">The PHMB-Ep resin was prepared as described in Example 1A.</p>
    <p num="132">Step 2: Preparation of spray formulation:</p>
    <p num="133">Spray formulation was prepared as follows:</p>
    <p num="134">
      --
      <br/>
      --        Component                   Amount, in grams
      <br/>
      --        BG-Bp resin                 14.651
      <br/>
      --        Sodium dodecyl sulfate (SDS) 0.828
      <br/>
      --        Silver nitrate (AgNO3) 0.138
      <br/>
      --        Potassium iodide (KI)       0.207
      <br/>
      --        1-Methyl-2-pyrrolidinone (NMP) 3.856
      <br/>
      --        Water                       203.416
      <br/>
      --        Ethanol                     776.903
    </p>
    <p num="135">
      The BG-Ep resin was put taken in 4-liter Erlenmeyer flask.
      <br/>
      Aqueous alcoholic solutions of NMP, SDS, KI and AgNO3 were added with uniform stirring.
      <br/>
      The entire solution was allowed to stir for a period of 2 hours to ensure uniform mixing and then filtered through a Whatman -4 filter paper and stored in appropriate package.
    </p>
    <p num="136">Example 11</p>
    <p num="137">Alcohol based disinfectant spray formulation involving unmodified biguanide:</p>
    <p num="138">
      The preparation of alcohol based disinfectant formulation was done in two steps.
      <br/>
      1. Preparation of spray concentrate involving Poly(hexamethylene) biguanide (PHMB).
      <br/>
      2. Preparation of disinfectant spray.
    </p>
    <p num="139">Step 1: Preparation of spray concentrate:</p>
    <p num="140">Spray concentrate was prepared as follows:</p>
    <p num="141">
      --
      <br/>
      --        Component                   Amount, in grams
      <br/>
      --        Cosmocil CQ                 800.0
      <br/>
      --        Sodium dodecyl sulfate (SDS) 105.12
      <br/>
      --        Silver iodide (AgI)         17.12
      <br/>
      --        Potassium iodide (KI)       60.48
      <br/>
      --        1-Methyl-2-pyrrolidinone (NMP) 120.0
      <br/>
      --        Ethanol                     1040.0
      <br/>
      --        Water                       288.0
    </p>
    <p num="142">
      The Cosmocil CQ was put in 4-liter Erlenineyer flask.
      <br/>
      Aqueous alcoholic solutions of SDS, AgI, KI and NMP were introduced into the solution with constant stirring.
      <br/>
      The entire solution was allowed to stir for a period of 2 hours to ensure uniform mixing and then filtered through a Whatman -4 filter paper and stored in appropriate package.
    </p>
    <p num="143">Step 2: Preparation of disinfectant spray:</p>
    <p num="144">Disinfectant spray was prepared as follows:</p>
    <p num="145">
      --
      <br/>
      --        Component                 Amount, in grams
      <br/>
      --        Ethanol                   1850.58
      <br/>
      --        Water                     491.93
      <br/>
      --        Spray Concentrate (from Step 1) 157.5
    </p>
    <p num="146">
      To a four liter Erlenmeyer flask, the required amounts of ethanol and water were added.
      <br/>
      The solution was allowed to mix for at least 10 minutes prior to the addition of spray concentrate.
      <br/>
      The spray concentrate was added dropwise over a period of 20-25 minutes with vigorous agitation.
      <br/>
      After completion of addition the solution was stirred for one hour at the same rate and room temperature.
      <br/>
      The solution was then filtered through a Whatman -4 filter paper and stored appropriately.
    </p>
    <p num="147">Equivalents</p>
    <p num="148">
      Those skilled in the art will be able to ascertain, using no more than routine experimentation, many equivalents of the specific embodiments of the invention described herein.
      <br/>
      These and all other equivalents are intended to be encompassed by the following claims.
    </p>
  </description>
  <claims format="original" lang="en" id="claim_en">
    <claim num="1">
      <claim-text>What is claimed is:</claim-text>
      <claim-text>1.</claim-text>
      <claim-text>A disinfectant composition comprising</claim-text>
      <claim-text>a film-forming antimicrobial material, an antimicrobial metallic material, and a carrier, wherein said composition, when applied to a surface, forms a non-permanent, adherent, water-insoluble film, wherein said metallic material is non-leachably bound to or associated with the film, wherein said film does not elute antimicrobial materials into contacting water at levels capable of inparting disinfecting action to said water, and wherein said film is removable by treatment with an alcohol solution.</claim-text>
    </claim>
    <claim num="2">
      <claim-text>2. The disinfectant composition of claim 1 wherein said carrier is a liquid.</claim-text>
    </claim>
    <claim num="3">
      <claim-text>3. The disinfectant composition of claim 1 wherein the alcohol solution further comprises a surfactant an emulsifier or a detergent.</claim-text>
    </claim>
    <claim num="4">
      <claim-text>4. The disinfectant composition of claim 1 wherein the film-forming antimicrobial material is an organic polymer.</claim-text>
    </claim>
    <claim num="5">
      <claim-text>5. The disinfectant composition of claim 4 wherein the organic polymer is a polymeric biguanide material.</claim-text>
    </claim>
    <claim num="6">
      <claim-text>6. The disinfectant composition of claim 1 wherein the antimicrobial metallic material is substantially water insoluble.</claim-text>
    </claim>
    <claim num="7">
      <claim-text>7. The disinfectant composition of claim 6 wherein said antimicrobial metallic material is selected from the group consisting of a metal, metal salt, metal complex, a metal alloy, and combinations thereof.</claim-text>
    </claim>
    <claim num="8">
      <claim-text>8. The disinfectant composition of claim 7 wherein said metal is silver.</claim-text>
    </claim>
    <claim num="9">
      <claim-text>9. The disinfectant composition of claim 7 wherein the metallic material is silver nitrate or silver iodide.</claim-text>
    </claim>
    <claim num="10">
      <claim-text>10. The disinfectant composition of claim 5 wherein the polymeric biguanide material comprises polyhexamethylene biguanide or derivatives thereof.</claim-text>
    </claim>
    <claim num="11">
      <claim-text>11. The disinfectant composition of claim 5 wherein the polymeric biguanide material comprises an adduct obtained by reacting said biguanide material with a water-insoluble organic compound.</claim-text>
    </claim>
    <claim num="12">
      <claim-text>12. The disinfectant composition of claim 11 wherein the water-insoluble organic compound is selected from the group consisting of epoxide compounds, isocyanate compounds, carboxylic acid compounds, acid chloride compounds, acid anhydride compounds, succimidyl ethers, aldehydes, ketones, alkyl methanesulfonates, alkyl trifluoromethanesulfonate compounds, alkyl para-toluenemethanesulfonate compounds and alkyl halide compounds.</claim-text>
    </claim>
    <claim num="13">
      <claim-text>13. The disinfectant composition of claim 12 wherein the water-insoluble organic compound is an epoxide compound selected from the group consisting of methylene-bis-N,N-diglycidylaniline, bisphenol-A-epichlorohydrin and N,N-diglycidyl-4-glycidyloxyaniline.</claim-text>
    </claim>
    <claim num="14">
      <claim-text>14. The disinfectant composition of claim 1 further comprising an optical reporter that enables visual detection of the presence of said film.</claim-text>
    </claim>
    <claim num="15">
      <claim-text>15. The disinfectant composition of claim 14 wherein said optical reporter is selected from the group consisting of a dye and an indicator.</claim-text>
    </claim>
    <claim num="16">
      <claim-text>16. The disinfectant composition of claim 15 wherein said indicator comprises a pH indicator.</claim-text>
    </claim>
    <claim num="17">
      <claim-text>17. The disinfectant composition of claim 15 wherein said indicator comprises a thermochromic material.</claim-text>
    </claim>
    <claim num="18">
      <claim-text>18. The disinfectant composition of claim 14 wherein said optical reporter comprises an optical brightening agent.</claim-text>
    </claim>
    <claim num="19">
      <claim-text>19. The disinfectant composition of claim 14 wherein said optical reporter comprises a fluorophore.</claim-text>
    </claim>
    <claim num="20">
      <claim-text>20. The disinfectant composition of claim 19 wherein said optical reporter is selected from the group consisting of 2,2'-(2,5-Thiophenediyl)bis5-tert-butylbenzoxazole or 4,4 '-bis-2-diethylamino-4-(2,5-disulphophenyl-amino)-s-triazinyl-6-amino-stilbene-2,2 '-disulphonic acid, sodium salt.</claim-text>
    </claim>
    <claim num="21">
      <claim-text>21. The disinfectant composition of claim 1 further comprising a surfactant, emulsifier, antioxidant or stabilizer.</claim-text>
    </claim>
    <claim num="22">
      <claim-text>22. The disinfectant composition of claim 21 wherein said surfactant is selected from the group consisting of sodium dodecyl sulfate sorbitan monooleate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate, polyoxyethylenesorbitan monolaurate, polyoxmethylenesorbitan mononpalmitate, polyoxetylenesorbitan monostearate, polyoxyetylenesorbitan monooleate or polyoxyetbylenesorbitan trioleate.</claim-text>
    </claim>
    <claim num="23">
      <claim-text>23. The disinfectant composition of claim 2 wherein the liquid carrier comprises water, an organic solvent, mixture of organic solvents or a combination of an organic and an aqueous solvent.</claim-text>
    </claim>
    <claim num="24">
      <claim-text>24. The disinfectant composition of claim 23 wherein said organic solvent is an antimicrobial disinfectant.</claim-text>
    </claim>
    <claim num="25">
      <claim-text>25. The disinfectant composition of claim 23 wherein the liquid carrier is an alkanol or an aqueous alkanol mixture.</claim-text>
    </claim>
    <claim num="26">
      <claim-text>26. The disinfectant composition of claim 25 wherein the alkanol is ethanol or isopropanol.</claim-text>
    </claim>
    <claim num="27">
      <claim-text>27. A method for providing an antimicrobial layer on a substrate, said method comprising: applying the disinfectant composition of claim 1 to said substrate to form an adherent, water insoluble layer or film on said substrate.</claim-text>
    </claim>
    <claim num="28">
      <claim-text>28. The method of claim 27 wherein said disinfectant composition is applied to said substrate by spraying from a spray applicator.</claim-text>
    </claim>
    <claim num="29">
      <claim-text>29. The method of claim 27 wherein said disinfectant composition is applied to said substrate by wiping, brushing or dipping.</claim-text>
    </claim>
    <claim num="30">
      <claim-text>30. The method of claim 27 wherein said disinfectant composition is applied to said substrate as an aerosol spray using a suitable propellant.</claim-text>
    </claim>
    <claim num="31">
      <claim-text>31. The method of claim 30 wherein the propellent is nitrogen, carbon dioxide or a hydrycarbon or a hydrocarbon mixture.</claim-text>
    </claim>
    <claim num="32">
      <claim-text>32. A hard surface disinfecting agent comprising the disinfectant composition of claim 1.</claim-text>
    </claim>
    <claim num="33">
      <claim-text>33. The hard surface disinfecting agent of claim 32 wherein said hard surface disinfecting agent is selected from the group consisting of hospital and institutional disinfectants, kitchen and bathroom disinfectants, cleaner disinfectants or floor and wall cleaners.</claim-text>
    </claim>
    <claim num="34">
      <claim-text>34. A skin disinfectant, an antiseptic, a sanitizer or a protectant comprising the disinfectant composition of claim 1.</claim-text>
    </claim>
    <claim num="35">
      <claim-text>35. The method of claim 27, wherein the substrate is a skin-contacting device or article.</claim-text>
    </claim>
    <claim num="36">
      <claim-text>36. The method of claim 34 wherein said skin-contacting device is selected from the group consisting of diapers, wound dressings, wipes, masks and surgical gowns.</claim-text>
    </claim>
    <claim num="37">
      <claim-text>37. The method of claim 27, wherein the substrate is a non-body contacting device or article.</claim-text>
    </claim>
    <claim num="38">
      <claim-text>38. The method of claim 37 wherein said non-body contacting article is selected from the group consisting of hospital bed rails, carpets and rugs.</claim-text>
    </claim>
  </claims>
</questel-patent-document>